SCHEMBL20140360

SCHEMBL20140360

CCc1ccc(Br)cc1C(O)c1ccc2c(c1)C1(C2)OCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20139451 0.78 KMT2A (0.42)
SCHEMBL20140180 0.74 SMN1; SMN2 (0.33)
SCHEMBL20139635 0.74 ALDH1A1 (0.36)
SCHEMBL20140089 0.73 TOP2A (0.38)
SCHEMBL22567691 0.72 APP (0.41)
SCHEMBL20140163 0.70 TOP2A (0.36)
SCHEMBL22567805 0.65 TDP2 (0.40)
SCHEMBL12291535 0.65 ADRB2 (0.38)
SCHEMBL407452 0.65 KMT2A (0.38)
SCHEMBL25908131 0.61 GABRA1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10815210-B2 Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators JANSSEN PHARMACEUTICA NV (BE) 2020-10-27 US disclosed
WO-2018089449-A1 BENZOCYCLOBUTANE DERIVATIVES USEFUL AS DUAL SGLT1/SGLT2 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-05-17 WO disclosed